
Teva-Handok has announced the appointment of Yoo Suk Hong as the first chief executive of the business venture between Teva …
Amphista doses first patient in AML trial of protein degrader
Jennings becomes President of Beckman Coulter Diagnostics
Boyds expands Regulatory Affairs team to support growing demand

